RELAXONSERelaxo Footwears Limited· Consumer DurablesHighNeutral
Announced Wed, 30 Jul, 2025 · 17:33 IST

Relaxo Footwears Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2025.

Revenue DeclineEbitda Margin ExpansionResults View source PDFExplain this filing

RELAXO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-6.4%Reaction day
₹483.50
prior close
₹466.70
announcement price
After-mkt
timing
Nifty Microcap 250market · index membership as recorded later (tracked since Jun 2026)-0.7%-5.6% vs market
Footwear peers, median of 9sector+0.0%-6.4% vs sector

On the reaction day the stock moved 5.6 pts less than Nifty Microcap 250 and 6.4 pts less than its Footwear peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.2
10m
-0.3
15m
+0.2
30m
+0.6
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-6.4-0.7-5.6+0.0-6.4
Next day
-8.3-2.3-6.0-2.0-6.3
2d
-8.5-1.8-6.7-2.1-6.4
3d
-9.8-2.1-7.7-2.9-6.9
4d
-9.0-3.2-5.8-5.0-4.0
5d
-6.7-3.5-3.2-5.6-1.2
1w
-10.1-4.1-6.0-7.7-2.4
15d
-1.4-2.0+0.5-4.6+3.2
1m
+0.5-3.4+3.9-4.0+4.5
2m
-8.4-5.1-3.3-4.6-3.8
3m
-9.7-1.3-8.4-5.9-3.8
UpDownMarket · Nifty Microcap 250Sector · Footwear peers, median of 9Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Relaxo Footwears has reported its Q1 FY26 results. Revenue from operations stood at INR 654.49 Cr, down from INR 748.19 Cr in Q1 FY25 — a decline of about 12.5% year-on-year. Profit for the period grew to INR 48.90 Cr from INR 44.37 Cr a year ago, a modest 10% rise. EPS stood at INR 1.78, flat versus the year-ago quarter. Despite weaker top-line, profitability improved, with EBITDA margin (PBT + finance costs + depreciation) rising to roughly 16.9% from about 13.9% last year. Statutory auditors Gupta & Dua issued an unmodified limited review report with no qualifications or emphasis of matter.

Likely market impact

Negative revenue growth signals continued demand weakness, but the healthy margin expansion shows cost discipline, which may support investor sentiment. Shareholders should watch whether the revenue slide reverses in coming quarters.